Preschool Depression Intervention Has Long-Term Beneficial Effects
THURSDAY, July 10, 2025 -- Completion of a Parent–Child Interaction Therapy-Emotion Development (PCIT-ED) intervention for preschool depression has long-term effects and is associated with reduced psychotropic and mental health service use, according to a study published online June 26 in the Journal of the American Academy of Child & Adolescent Psychiatry.
Mei Elansary, M.D., M.Phil., from the Boston University School of Medicine, and colleagues examined whether response to PCIT-ED was evident four years after treatment completion and whether those who were remitted had decreases in mental health service use and psychotropic prescriptions. Participants from a randomized controlled trial of PCIT-ED delivered during the preschool period were followed into preadolescence.
The researchers found that at preadolescence, there was a high rate of remission (57.1 percent). Relapse was predicted by posttherapy externalizing symptoms. Significantly lower rates of lifetime use of alpha-agonist, antidepressant, and atypical antipsychotic medication and lower utilization of intensive mental health interventions were seen among participants with remission at preadolescence.
"Our results offer promising evidence that PCIT-ED can reduce the risk of future mental health challenges into preadolescence," lead author Joan L. Luby, M.D., from the Washington University School of Medicine in St. Louis, said in a statement. "Perhaps most strikingly, children who achieved remission required significantly less use of psychotropic medications and intensive mental health services, suggesting a more favorable long-term trajectory."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Psilocybin-Assisted Therapy Aids Symptoms of Major Depressive Disorder
THURSDAY, Sept. 25, 2025 -- Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study...
Suicidal Ideation Risk Elevated for Patients With Atopic Eczema
WEDNESDAY, Sept. 17, 2025 -- Patients with atopic eczema (AE) have an increased risk for suicidal ideation (SI), according to a study presented at the European Academy of...
Parental Diseases of Despair Linked to Suicidal Events in Offspring
MONDAY, Sept. 15, 2025 -- Parental diseases of despair (DoD; i.e., substance use disorder, alcohol-related disease, or suicidal behavior) are associated with suicidal events (SE)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.